Evaluation of a Third and Fourth Dose of StaphVAX® in Adults With End-Stage Renal Disease

NCT00130260 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

99

Enrollment

INDUSTRY

Sponsor class

Stopped unsatisfactory efficacy data from preceding trial

Conditions

Staphylococcal Infections
Chronic Kidney Failure

Interventions

BIOLOGICAL: Staph aureus types 5 and 8 conjugate vaccine
BIOLOGICAL: placebo

Sponsor

Nabi Biopharmaceuticals